The departure of leading AI researchers from Google to found Discovery Loop raises important questions about the future ...

A small molecule inhibitor developed at Virginia Commonwealth University has demonstrated the ability to eliminate cancer ...

Oblenio Bio has dosed the first patients in a Phase 1a trial of LBL-051, a tri-specific T cell engager designed to ...

Voyager Therapeutics has presented six-month GLP toxicology data for VY1706, its investigational tau-targeting gene therapy, ...

A new gene therapy platform exploiting the brain's glymphatic transport system and engineered AAV5 vectors could offer a ...

A three-drug combination targeting shared metabolic vulnerabilities in cancer and senescent cells has improved physical ...

Most inherited retinal diseases still have no approved therapy despite advances in gene therapy. This article explores why ...

What if one of gene therapy's biggest obstacles isn't delivery, but the body's own cells? Discover why DNA silencing is ...

A newly identified mitochondrial microprotein, MENTSH, has been linked to increased Type 2 diabetes susceptibility in Mexican ...

A landmark genome-wide study of more than 2.5 million adults has identified 26 genomic regions linked to fibromyalgia, ...

Antibody-drug conjugates (ADCs) present unique toxicology challenges. Learn which endpoints matter most, how they inform ...

A new study published in Science identifies a specialised dendritic cell subset as the cellular architects behind tertiary ...